Wilson Sonsini Goodrich & Rosati advised Cellino on the deal. Cellino Biotech, an autonomous cell therapy manufacturing company, announced the completion of a Series A financing...
Cellino’s $80 Million Series A Financing
IDX’s Business Combination with ZeroFox and L&F Acquisition Corp.
Wilson Sonsini Goodrich & Rosati advised IDX on the deal. Kirkland & Ellis counseled L&F Acquisition Corp. (NYSE: LNFA) on the deal. Venable and Ogier represented...
Helix’s $50 Million Series C Funding
Wilson Sonsini Goodrich & Rosati advised Temasek on the deal. Helix, the leading population genomics and COVID-19 testing company, announced that it has closed a $50...
WuXi AppTec’s Acquisition of OXGENE
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised WuXi AppTec on the deal. WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in...